ArticleJournal of experimental & clinical cancer research : CR2021

ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling.

Hao Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.